Special Briefing Jeremy P. Lewin, Senior Official Under Secretary for Foreign Assistance, Humanitarian Affairs, and Religious Freedom Mignon Houston, Deputy Spokesperson November 17, 2025 MS HOUSTON: Good morning and welcome, everyone, to today’s press call on the America First Global Health Strategy and its groundbreaking partnership to expand access to lenacapavir in high-burden HIV countries. This initiative, led by the Department of State in close coordination with Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis, and Malaria, is a powerful demonstration of what is possible when government, industry, and global institutions unite around a shared purpose. Today’s press call provides important updates following our on-the-record call in September, when this partnership was first announced. Since then our collective work has continued with urgency and a shared belief in the transformative potential of this collaboration. I am Mignon Houston, the deputy spokesperson for the Department of State, and I’ll serve as your moderator for today’s call. Before we begin, I would like to go over a few ground rules. Today’s call is on-the-record, and all remarks may be attributed to each speaker by name and title. The contents of this call are embargoed until 5:00 a.m. Eastern Time. Once again, the contents – we ask the contents are embargoed until 5:00 a.m. Eastern Standard Time. We are honored to welcome back our three distinguished speakers for the on-the-record remarks and Q&A. Our first speaker, Jeremy Lewin, senior official for Foreign Assistance, Humanitarian Affairs, and Religious Freedom here at the Department of State; Daniel O’Day, chairman and chief executive officer of Gilead Sciences; Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis, and Malaria. At this time, we are ready to begin our on-the-record opening remarks, and we’ll begin with our senior official from the Department of State, Mr. …
Source: MyPR International

